10x Genomics (TXG) Other financing activities (2018 - 2026)

10x Genomics (TXG) has 9 years of Other financing activities data on file, last reported at $273000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 35.31% year-over-year to $273000.0; the trailing twelve-month figure through Mar 2026 stood at -$149000.0 (down 101.54% YoY), and the FY2024 full-year result was $10.9 million, up 87.72% from the prior year.
• Other financing activities improved to $273000.0 in Q1 2026, from -$4.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $8.1 million in Q3 2023 to a low of -$8.8 million in Q3 2022.
• A 5-year average of $1.4 million and a median of $2.0 million in 2023 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 295.51% in 2025, while the deepest fall reached 200.97% in 2025.
• Tracing TXG's Other financing activities over 5 years: stood at -$8.8 million in 2022, then advanced by 8.21% to -$8.1 million in 2023, then soared by 156.07% to $4.5 million in 2024, then slumped by 200.97% to -$4.6 million in 2025, then jumped by 105.99% to $273000.0 in 2026.
• Business Quant data shows TXG's Other financing activities at $273000.0 in Q1 2026, -$4.6 million in Q4 2025, and $617000.0 in Q3 2025.